Details for Patent: 9,566,244

Which drugs does patent 9,566,244 protect, and when does it expire?

Patent 9,566,244 protects APTIOM and is included in one NDA.

This patent has thirty-three patent family members in twenty-two countries.

Summary for Patent: 9,566,244

Title:	Pharmaceutical composition comprising licarbazepine acetate
Abstract:	A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also disclosed is a granulation process, especially a wet granulation process, for making the pharmaceutical composition.
Inventor(s):	Cardoso de Vasconcelos; Teofilo (S. Mamede do Coronado, PT), dos Santos Lima; Ricardo Jorge (S. Mamede do Coronado, PT), Cerdeira de Campos Costa; Rui (S. Mamede do Coronado, PT)
Assignee:	BIAL-PORTELE & CA, S.A. (S. Mamede do Coronado, PT)
Application Number:	14/108,615
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,566,244
Patent Claim Types: see list of patent claims	Composition; Formulation; Device; Dosage form;

Drugs Protected by US Patent 9,566,244

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sumitomo Pharma Am	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-001	Nov 8, 2013	AB	RX	Yes	No			Y
Sumitomo Pharma Am	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-002	Nov 8, 2013	AB	RX	Yes	No			Y
Sumitomo Pharma Am	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-003	Nov 8, 2013	AB	RX	Yes	No			Y
Sumitomo Pharma Am	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-004	Nov 8, 2013	AB	RX	Yes	Yes			Y

International Family Members for US Patent 9,566,244

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	069031
Australia	2008317584
Brazil	PI0818680
Canada	2703313
China	101848698
Cyprus	1118350